Goldman Sachs
ERNA icon

Goldman Sachs’s Eterna Therapeutics ERNA Stock Holding History

Goldman Sachs’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-665
Closed -$3.31K – 6698
2026
Q1 		$3.31K Buy
+665
New +$10.6K ﹤0.01% 6411
2025
Q2 		– Sell
-48
Closed -$3.21K – 6169
2025
Q1 		$3.21K Buy
48
+14
+41% +$1.73K ﹤0.01% 5999
2024
Q4 		$3.77K Buy
+34
New +$9.22K ﹤0.01% 5960
2023
Q3 		– Sell
-30
Closed -$25.5K – 5633
2023
Q2 		$25.5K Buy
+30
New +$30.3K ﹤0.01% 5528
2022
Q4 		– Sell
-10
Closed -$19K – 6054
2022
Q3 		$19K Sell
10
-3
-23% -$10.3K ﹤0.01% 5948
2022
Q2 		$48K Buy
13
+8
+160% +$57.4K ﹤0.01% 6033
2022
Q1 		$79K Sell
5
-4
-44% -$75.9K ﹤0.01% 6171
2021
Q4 		$293K Buy
9
+6
+200% +$326K ﹤0.01% 5681
2021
Q3 		$182K Buy
+3
New +$259K ﹤0.01% 5754
2017
Q1 		– Sell
-1
Closed -$112K – 6821
2016
Q4 		$112K Hold
1
– – ﹤0.01% 6086
2016
Q3 		$123K Hold
1
– – ﹤0.01% 6127
2016
Q2 		$192K Buy
+1
New +$113K ﹤0.01% 5717
2016
Q1 		– Hold
0
– – – 6695
2015
Q4 		– Hold
0
– – – 6890
2015
Q3 		– Hold
0
– – – 6912
2015
Q2 		– Hold
0
– – – 7056
2015
Q1 		– Hold
0
– – – 6742
2014
Q4 		– Hold
0
– – – 6841
2014
Q3 		– Hold
0
– – – 6907
2014
Q2 		– Hold
0
– – – 6734
2014
Q1 		– Hold
0
– – – 6647
2013
Q4 		– Hold
0
– – – 6595

Other funds holding ERNA

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tradewinds Capital Management Bellingham, Washington $563M AUM 41.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Goldman Sachs's ERNA Position: Q2 2026 in Review

Goldman Sachs sold out of Eterna Therapeutics (ERNA) in Q2 2026, closing a stake of 665 shares — an estimated $3.31K sold.

Goldman Sachs first reported a position in ERNA in Q2 2016 and held it in 12 quarters. The position peaked at $293K in Q4 2021. 9 funds tracked by Wall St. Rank hold ERNA as of Q2 2026.

  • Goldman Sachs reported no remaining Eterna Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 665 Eterna Therapeutics shares in Q2 2026, an estimated $3.31K.
  • Goldman Sachs first reported a position in Eterna Therapeutics in Q2 2016 and held it in 12 quarters.
  • Goldman Sachs's Eterna Therapeutics position peaked at $293K in Q4 2021.
  • 9 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.